Biomx Inc logo

PHGE - Biomx Inc News Story

$6.48 -0.3  -3.9%

Last Trade - 4:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £257.1m
Enterprise Value £216.2m
Revenue £n/a
Position in Universe 3941st / 6851

BUZZ-BiomX Inc: Rises on therapy to target bacteria in colorectal cancer patients

Thu 10th December, 2020 10:20am
** Drug developer's shares  PHGE.K  rise 11% to $6.64
premarket
    ** Co says successfully engineered a gene payload to target
a type of bacteria present in tumors of patients with colorectal
cancer
    ** Analysis confirmed presence of a target bacteria called
Fusobacterium nucleatum in over 80% of such tumor samples - PHGE
 urn:newsml:reuters.com:*:nBw4hpk8ca
    ** PHGE's colorectal cancer program uses phage therapy or
bacteria-attacking virus with checkpoint inhibitors to target
such bacteria    
    ** Up to Wednesday's close, stock down 38.3% YTD

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.